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Key Points: At US children’s hospitals, 35% of children are receiving one or more antibiotics at any 
given time, and 26% of these children are receiving suboptimal antibiotics. Nearly half of suboptimal 
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Background: Studies estimate that 30-50% of antibiotics prescribed for hospitalized patients are 
inappropriate, but pediatric data are limited. Characterization of inappropriate prescribing practices 
for children are needed to guide pediatric antimicrobial stewardship. 
Methods: Cross-sectional analysis of antibiotic prescribing at 32 US children’s hospitals. Subjects 
included hospitalized children with ≥1 antibiotic order at 0800 on one day per calendar quarter, over 
six quarters (Quarter 3 2016 – Quarter 4 2017). Antimicrobial stewardship program (ASP) physicians 
and/or pharmacists used a standardized survey to collect data on antibiotic orders and evaluate 
appropriateness. The primary outcome was the percentage of antibiotics prescribed for infectious 
use that were classified as suboptimal, defined as inappropriate or needing modification. 
Results: Of 34 927 children hospitalized on survey days, 12 213 (35.0%) had ≥1 active antibiotic 
order. Among 11 784 patients receiving antibiotics for infectious use, 25.9% were prescribed ≥1 
suboptimal antibiotic. Of the 17 110 antibiotic orders prescribed for infectious use, 21.0% were 
considered suboptimal. Most common reasons for inappropriate use were bug-drug mismatch 
(27.7%), surgical prophylaxis >24 hours (17.7%), overly broad empiric therapy (11.2%), and 
unnecessary treatment (11.0%). The majority of recommended modifications were to stop (44.7%) 
or narrow (19.7%) the drug. ASPs would not have routinely reviewed 46.1% of suboptimal orders. 
Conclusions: Across 32 children’s hospitals, approximately 1 in 3 hospitalized children are receiving 
one or more antibiotics at any given time. One quarter of these children are receiving suboptimal 
therapy, and nearly half of suboptimal use is not captured by current ASP practices. 
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 Antibiotics are prescribed frequently for children. Among pediatric outpatients, they are the 
most commonly prescribed drug class [1], and over half of hospitalized United States (US) children 
receive antibiotics [2,3]. While antibiotics are life-saving medications, their use is not free from 
adverse effects. Antibiotic use contributes to antibiotic resistance [4,5]; infections with resistant 
organisms incur substantial morbidity and mortality and are predicted to become a major cause of 
worldwide mortality [6–8]. Antibiotic use also promotes the development of C. difficile infection [9] 
and is the leading cause of emergency department visits for adverse drug events in children [10]. 
Judicious antibiotic use is therefore paramount to preventing unintended harm and limiting the 
development of antibiotic resistance. 
To date, evaluation of appropriate pediatric antibiotic prescribing in US populations has 
been most extensive in outpatient settings [11,12]. While multiple studies in adult inpatient 
populations have demonstrated that 30% - 50% of antibiotics are prescribed inappropriately [13–
15], few studies have focused on US pediatric populations, and these reflect only single centers or 
specific diagnoses or interventions [16–18]. Outside the US, studies have attempted to quantify 
inappropriate prescribing in hospitalized children more broadly [19–30]. However, application of 
these data to US populations is limited by country-specific factors such as regional disease burden 
and antibiotic resistance patterns, as well as risk tolerance and hierarchical structure that influence 
antibiotic prescribing [31]. Furthermore, most studies do not include detailed assessments of 
prescribing appropriateness. Such data are needed to inform antimicrobial stewardship efforts for 
hospitalized children. To address these gaps, a multicenter study utilizing serial point prevalence 
surveys was undertaken to comprehensively evaluate antimicrobial utilization and appropriateness 
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Study Design and Setting 
A serial, cross-sectional analysis of antibiotic prescribing at 32 US children’s hospitals was 
conducted from July 2016 through December 2017. Participating hospitals were recruited from the 
Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS) Collaborative [32]. The SHARPS 
Collaborative includes over 60 freestanding children’s hospitals or tertiary children’s hospitals within 
a larger medical system. Each hospital completed up to six single-day surveys of antimicrobial use. 
Surveys were completed within a specified three-week period during each calendar quarter, with 
individual hospitals selecting their survey date. Institutional review board (IRB) approval was 
obtained at Children’s Mercy-Kansas City (CMH, the coordinating center) and at hospitals that did 
not adopt central IRB approval through CMH.  
 
Study Population 
Patients 0-17 years of age admitted at 0800 on the day of each quarterly survey with an 
active order for an enteral, parenteral (intravenous, intramuscular, intrathecal, or intraperitoneal), 
inhaled, or rectal antimicrobial were included. 
 
Data Collection 
Data collection was performed by physician and/or pharmacist members of each hospital’s 
antimicrobial stewardship program (ASP). Data were collected via a standardized data collection 
form utilized by the Global Antimicrobial Resistance and Prescribing in Neonates and Children 
(GARPEC) project [25], with the addition of questions developed by the SHARPS Collaborative to 
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Data Capture) [33,34] database hosted at CMH. On survey days, hospitals collected census data and 
identified patients with active antimicrobial orders via the electronic medical record. Chart review 
was performed to collect patient-specific clinical and antimicrobial data, including dose, route, 
indication, and if/when the ASP would routinely review the antimicrobial (Supplemental Material, 
Appendix A).  
For antibiotics, hospitals assessed 1) appropriateness of each order, based on clinical 
judgment of the ASP physician or pharmacist, and 2) whether the ASP would recommend 
modification of the order were it reviewed as part of routine ASP activities. For inappropriate 
antibiotics, hospitals selected from pre-specified reasons for inappropriateness: 1) bug-drug 
mismatches that require narrowing or broadening therapy based on culture and susceptibility or 
rapid diagnostics, 2) unnecessary duplicate therapies (e.g. double anti-anaerobic coverage or double 
gram-negative coverage for non-carbapenemase-resistant Enterobacteriaceae infections), 3) highly 
bioavailable antibiotics being administered intravenously in a patient currently receiving enteral 
feeds or medications; 4) surgical prophylaxis >24 hours, and 5) other. “Other” included any 
additional reasons that antibiotic use was judged to be inappropriate based on routine ASP practices 
at each site, and if selected, was accompanied by free text explanation. For antibiotics needing 
modification, hospitals selected from a pre-specified list of 18 reasons for modification (e.g. Stop 
[without a change to another antibiotic], Narrow empirically, Narrow based on culture and 
susceptibility [Supplemental Material, Appendix A]), or selected other, with free text explanation. 
Hospitals could only record one inappropriate reason and one modification per antibiotic and were 
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Data Analysis  
Data from all surveys were pooled for analysis. After initial description of antimicrobial 
prevalence, we restricted the analysis to antibiotics prescribed for infectious use (infection 
treatment or prophylaxis), excluding antibiotics prescribed for non-infectious indications (e.g. 
gastrointestinal motility). Orders were classified as infectious or non-infectious based on the 
reported indication. For indications listed as “other,” the accompanying free text was used to re-
classify the order into an existing indication category or to generate additional categories 
(Supplemental Material, Appendix B). 
The primary outcome was the percentage of antibiotic orders classified as suboptimal, 
defined as those classified as inappropriate, requiring a modification, or both. Secondary outcomes 
included the frequencies of individual drug use, indications, inappropriate reasons, recommended 
modifications, and ASP review status for each antibiotic. A substantial proportion of antibiotics were 
classified as inappropriate with a reason of “other.” Therefore, additional post-hoc inappropriate use 
categories were created, with re-classification of “other” reasons into these categories 
(Supplemental Material, Appendix C). 
Additional analysis was conducted to assess factors associated with suboptimal antibiotic 
use. For this analysis, antibiotics were grouped into classes (Supplemental Material, Appendix D). 
Bivariate analysis was conducted to assess the association of suboptimal antibiotic use with 
antibiotic class, indications, and patient characteristics. A multilevel, generalized linear model was 
used to examine how the odds of suboptimal antibiotic use related to prescribing-level (e.g., 
antibiotic class, indication for treatment) and patient-level (e.g., chronic conditions, medical service 
type, ventilation status) covariates.  Random intercept models were constructed using the 
participating hospital as a random effect and employing compound symmetry for the covariance 
matrix.  Fit statistics and assessment for confounding were used to identify parsimonious models.  






/cid/advance-article-abstract/doi/10.1093/cid/ciaa036/5707319 by St G
eorge's U





Study Population and Antibiotic Prevalence 
Thirty-two hospitals contributed one or more quarters of survey data, and 16 hospitals 
contributed data in all six quarters. Among 34927 patients admitted across all survey days, 13051 
(37.4%) had one or more active antimicrobial orders (22196 antimicrobial orders total). Antibiotics 
were prescribed for 12213 (35.0%) patients, totaling 17844 orders (80.4% of all antimicrobial orders; 
68.1% administered parenterally, 30.5% enterally, 1.4% inhaled). Other antimicrobials included 
antifungals (2822 [12.7%]), antivirals (1374 [6.2%]), and antiparasitics (97 [0.4%]). Infectious use 
accounted for 17110 (95.9%) antibiotic orders and 11784 (96.5%) patients receiving antibiotics (7475 
[63.4%] receiving one antibiotic, 3489 [29.6%] receiving two, and 820 [7.0%] receiving three or 
more), and all further results referring to antibiotics include only these orders and patients. 
Median age among patients receiving antibiotics was 3.8 years (interquartile range: 0.5, 11.0 
years, Table 1), and 6452 (55.0%) were male. Half of patients were admitted to medical services, 
followed by non-neonatal intensive care units (ICUs; 21.4%). Most patients (77.2%) had ≥1 chronic 
condition, and 34.5% had two or more. 
 Sulfamethoxazole and trimethoprim (SMX/TMP) was the most commonly prescribed 
antibiotic, accounting for 1880 (11.0%) orders, followed by ceftriaxone (9.2%), vancomycin (9.1%), 
and piperacillin/tazobactam (7.0%; Figure 1). The top 10 ordered antibiotics accounted for 68.9% of 
antibiotic orders and were prescribed primarily (>90%) for treatment, except SMX/TMP and 
cefazolin (87.3% and 77.2% prescribed for prophylaxis, respectively). Treatment for bacterial lower 
respiratory tract infection (LRTI) was the most common indication (17.5%), followed by prophylaxis 
for medical problems (15.9%), probable or proven sepsis (13.9%) and prophylaxis for surgical 






/cid/advance-article-abstract/doi/10.1093/cid/ciaa036/5707319 by St G
eorge's U




Suboptimal Antibiotic Use 
Analysis of suboptimal use (inappropriate and/or requiring modification) was able to be 
performed for 16891 (98.7%) antibiotic orders. Of these, 3544 (21.0%) were considered suboptimal, 
with 2293 (13.6%) classified as inappropriate and 1235 (7.3%) classified as appropriate but needing 
modification. A recommended modification was recorded for nearly all suboptimal antibiotics 
(n=3458 [97.6%]). Overall, 3027 (25.9%) patients receiving antibiotics were prescribed ≥1 suboptimal 
antibiotic (inter-hospital range: 7.4% - 46.8%, Figure 3). The percentage of orders judged suboptimal 
did not differ between hospitals that completed six vs. less than six surveys (20.7% vs. 21.4%, 
P=0.288) or by season (Q1: 21.8%, Q2: 20.1%, Q3: 21.5%, Q4: 20.4%; P=0.185). 
Among suboptimal antibiotic orders classified as inappropriate, the most frequent reasons 
for this classification were bug-drug mismatches that required narrowing or broadening of therapy 
based on culture and susceptibility or rapid diagnostics (n=635 [27.7%]) and surgical prophylaxis >24 
hours (n=407 [17.7%]; Figure 4). Among suboptimal antibiotics with a recommended modification, 
ASPs recommended stopping 1583 (44.7%) antibiotics without replacement (Figure 5). An additional 
698 (19.7%) antibiotics warranted replacement with a narrower-spectrum antibiotic, either 
empirically or based on culture results. Need for dose modification (changes to dose amount or 
frequency) accounted for 12.7% of suboptimal antibiotics. 
While SMX/TMP was the most frequently ordered antibiotic, only 8.5% of SMX/TMP orders 
were suboptimal (Figure 1). SMX/TMP medical prophylaxis was rarely judged suboptimal (69/1535 
orders [4.5%]), in contrast to 28.8% (88/305) of SMX/TMP prescribed for other reasons. Of the 
remaining top 10 antibiotics, cefazolin, clindamycin, and vancomycin were most often suboptimal 
(28.7%, 26.7%, and 25.7%, respectively). However, the drugs most often considered suboptimal 
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generation cephalosporins (cefpodoxime, cefixime, and cefdinir; 44/90 orders [48.9%]), second-
generation cephalosporins without anaerobic activity (cefprozil and cefuroxime; 17/48 [35.4%]) and 
ciprofloxacin (101/301 [33.6%]).  
By indication, the greatest number of suboptimal orders were prescribed for proven or 
probable bacterial LRTI (n=655, 22.0% of bacterial LRTI indications, Figure 2). However, the 
indications with the greatest percentage of suboptimal orders were surgical prophylaxis, with 588 
(39.8%) of 1476 orders classified as suboptimal, along with upper respiratory tract infections 
(211/631 [33.4%]), viral LRTI (48/64 [75.0%]), urinary tract infections (180/560 [32.1%]), fever of 
unknown origin (24/69 [34.8%]), and unknown indications (123/270 [45.6%]). Among all suboptimal 
orders, bacterial LRTI, surgical prophylaxis, and probable or proven sepsis accounted for almost half 
(18.5%, 16.6%, and 12.9%, respectively). 
 Suboptimal prescribing also varied by clinical characteristics. Of patients receiving 
antibiotics, 33.6% (827/2459) in non-neonatal ICUs were prescribed ≥1 suboptimal antibiotic, 
followed by surgical services (472/1673 [28.2%]), neonatal ICUs (354/1531 [23.1%]), and medical 
services (1303/5790 [22.5%]). Among those receiving invasive ventilation, 32.9% (718/2180) of 
patients receiving antibiotics were prescribed suboptimal antibiotics, followed by 25.4% (354/1393) 
of those receiving non-invasive ventilation and 24.1% (1912/7919) of those receiving no ventilation. 
Suboptimal prescribing occurred in 24.2% (645/2021) of patients without chronic conditions, 25.4% 
(1260/3709) of patients with one chronic condition, and 27.7% (1115/4023) of patients with 2 
chronic conditions. 
 
Factors Associated with Suboptimal Prescribing 
 On bivariate analysis, suboptimal prescribing was not associated with sex, patient age or 
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conditions, ventilation status and medical service type. However, these patient-level characteristics 
did not provide meaningful improvement based on the fit statistics of the multilevel regression 
models, and a more parsimonious model was chosen as the final model. After adjusting for 
indication and treatment documentation, several antibiotic classes were significantly associated with 
suboptimal prescribing, compared with narrow-spectrum penicillins (Table 2). Oral third-generation 
cephalosporins, carbapenems, fluoroquinolones, broad-spectrum gram-positive agents (e.g. 
linezolid, daptomycin), and vancomycin had the highest odds of suboptimal prescribing. Among 
treatment indications, the odds of suboptimal prescribing were significantly higher for several 
indications compared to medical prophylaxis, including viral LRTI, unknown indications, and surgical 
prophylaxis.  
 
Antimicrobial Stewardship Review 
ASPs would not have reviewed 1626 (46.1%) suboptimal antibiotics through routine ASP 
activities. Among antibiotics routinely reviewed by ASPs, the percentage of suboptimal orders 
decreased following routine ASP review: 24.8% (873/3519) among antibiotics awaiting routine 
review, 19.7% (837/4245) among antibiotics reviewed in the past 5 days, and 12.9% (192/1483) 
among antibiotics reviewed >5 days ago (P=<0.001). Among antibiotics not routinely reviewed by 
ASPs, 21.4% (1626/7602) were suboptimal; of these, cefazolin, clindamycin, and ceftriaxone were 
most common (11.4%, 9.9%, and 9.7% of suboptimal, unreviewed antibiotics, respectively). 
 
DISCUSSION 
In this multicenter study of nearly 35000 hospitalized children, 35% were receiving one or 
more antibiotics on survey days. Of those receiving antibiotics for infectious use, 26% were 
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would not have been reviewed by ASPs as part of their routine daily work. These data underscore 
the need for robust programs to support optimal antibiotic use for hospitalized children. 
Previous studies of antibiotic use in US children’s hospitals indicate that approximately 60% 
of children receive an antibiotic at some time during their stay [2,3]. Our calculation of antibiotic 
prevalence is not directly comparable because we measured active orders on a single day and 
instead provides an additional metric to describe antibiotic use in hospitalized children. This 
prevalence is similar to the 2012 worldwide ARPEC point prevalence survey, in which 37% of 
pediatric inpatients received antimicrobials on survey days, of which 86% were antibiotics [29]. 
We found a lower rate of suboptimal prescribing than has been reported in US adult 
populations (30-50%) [13–15]. Our rate was also lower than that of a small study in Turkish children 
(34%) [23], but higher than the rate reported among 631 hospitalized children in Australia (18%) [30] 
and 336 children in Sweden (<10% when guidelines available) [28]. Most suboptimal use in our study 
was related to over-prescribing: ASPs would have recommended stopping nearly half of suboptimal 
antibiotics, and another 20% warranted replacement with a narrower-spectrum antibiotic. There 
was also considerable variability in the degree of suboptimal prescribing, with up to 47% of patients 
receiving suboptimal antibiotics at some hospitals. This variability warrants further investigation and 
may identify opportunities for hospitals to improve ASP efforts and prescribing. Importantly, many 
hospitals in this study have well-established ASPs, so these results may underestimate the rate of 
suboptimal prescribing at hospitals with newer ASPs or those without pediatric ASPs. 
This study highlights areas in which ASPs can focus efforts to further optimize antibiotic use. 
Bacterial LRTI was the most common indication for antibiotic use, consistent with previous studies in 
US and global pediatric populations [3,25,29], and accounted for the largest share of suboptimal 
orders (18%), making it a prime target for additional ASP intervention. Surgical prophylaxis, most 
commonly prolonged duration, also accounted for a substantial portion of suboptimal orders (17%) 
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CDC guidelines for prevention of surgical site infection recommend limiting antibiotic prophylaxis for 
clean and clean-contaminated procedures to a single pre-operative dose [35]. Thus, an even greater 
proportion of surgical prophylaxis in our study would likely now be considered suboptimal, as our 
pre-specified criterion for inappropriate surgical prophylaxis allowed up to 24 hours of prophylaxis. 
 Our study also examined suboptimal use by drug class, a common framework through which 
ASPs structure their reviews. After adjusting for indication and treatment documentation, drug 
classes with the highest odds of being considered suboptimal included oral third general 
cephalosporins, broad-spectrum gram-positive agents, carbapenems, clindamycin, metronidazole, 
fluoroquinolones, and vancomycin. Many ASPs review only certain antibiotics; such ASPs should 
consider evaluating these and other drug classes associated with higher odds of suboptimal 
prescribing if they are not reviewed routinely. 
Arguably the most important finding of our study is that nearly half of suboptimal orders 
would not have been routinely reviewed by ASPs. Additionally, the rate of suboptimal use among 
antibiotics that ASPs would not routinely review (21%) was only slightly lower than that of orders 
that the ASP would be reviewing soon (25%). These data demonstrate that antibiotics not currently 
targeted for routine review still have significant need for ASP oversight. While extension of routine 
review to all antibiotics is an obvious solution, this is resource-intensive and may not be feasible at 
all hospitals. ASPs may need to consider alternative strategies to address additional suboptimal use, 
such as guideline development, use of order sets, or required order end dates. ASPs also need to 
develop strategies to identify additional areas of suboptimal use, such as periodic review of all 
antibiotics for appropriateness. Encouragingly, rates of suboptimal prescribing among routinely 
reviewed antibiotics were lower among orders that had already undergone routine ASP review by 
the survey day, compared to those yet to be reviewed. This suggests that ASP recommendations are 
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 This study has several strengths due to its multicenter design, detailed data collection, 
capture of data in all seasons, and systematic assessment of antibiotic appropriateness, but 
limitations exist. First, data collection was limited to six single-day surveys per institution. Second, 
we lacked a standard definition for “inappropriateness” which may have led to inconsistent 
assessment of this outcome. This was partially mitigated by providing an operations manual to all 
sites with guidance on survey completion and by discussion on monthly webinars hosted by the 
SHARPS Collaborative. Additionally, the composite outcome of suboptimal use captured all 
antibiotics on which ASPs would act, regardless of inappropriate classification. Furthermore, a 
recommended modification was recorded for 98% of suboptimal orders, enabling a thorough 
understanding of ASP assessment of these orders. Characterization of inappropriate use was also 
limited by the need for post-hoc analysis of free text comments in almost 40% of orders classified as 
inappropriate. Finally, not all centers participated in each survey, which may have biased our results 
towards centers that participated more consistently. Patient volume also varied by institution, so 
larger hospitals may have disproportionately influenced the prevalence of suboptimal use. 
 In summary, antibiotic use is common among hospitalized US children, and high rates of 
suboptimal use persist, despite ASP efforts. While current ASP review practices capture many 
suboptimal antibiotic orders, a substantial proportion remain unaddressed. This study highlights the 
need for ASPs to look beyond current practices to identify and intervene upon additional suboptimal 
use and denotes areas in which to potentially expand efforts. Such evolution is imperative to ensure 







/cid/advance-article-abstract/doi/10.1093/cid/ciaa036/5707319 by St G
eorge's U




*SHARPS Collaborative Authors: 
Holly Maples, Hoang Huynh, Kanokporn Mongkolrattanothai, Hayden Schwenk, Betty P. Lee, Fouzia 
Naeem, Brenik Kuzmic, Amanda Hurst, Sarah Parker, Jennifer Girotto, Nicholas Bennett, Rana F. 
Hamdy, Benjamin M Hammer, Shannon Chan, Katie Namtu, David Berman, Preeti Jaggi, AJ 
Fernandez, Craig Shapiro, Margaret Heger, George Johnson, Sameer J. Patel, Leslie Stach, Tony 
Scardina, Kristen Nichols, John Manaloor, Sarah Jones, Rosemary Olivero, Sara Ogrin, Terri L. 
Stillwell, Elizabeth C. Lloyd, Jennifer Goldman, Karisma Patel, Diana Yu, Miranda Nelson, David 
Rosen, Andrea Green, Jennifer Zweiner, Joshua Courter, David Haslam, Saul R. Hymes, Preeti Jaggi, 
Jessica Tansmore, Talene Metjian, Kelly Lee, Sandra Arnold, Luis Castagnini, Sarah Kubes, Marc 
Mazade, Michelle Crawford, Kathryn Merkel, Marisol Fernandez, Michael Chang, Hillary Orr, Jared 




This work was supported by an investigator-initiated grant from Merck. 
 
CONFLICTS OF INTEREST 
Potential conflicts of interest. J.G.N. and B.R.L. received grant support from Merck to 
complete this study. A.C.T., K.B.F., L.K.H., J.S.G., A.L.H., M.P.K., C.M.T., and M.S. have 








/cid/advance-article-abstract/doi/10.1093/cid/ciaa036/5707319 by St G
eorge's U





1.  Chai G, Governale L, McMahon AW, Trinidad JP, Staffa J, Murphy D. Trends of 
Outpatient Prescription Drug Utilization in US Children, 2002-2010. Pediatrics 2012; 
130:23–31.  
2.  Gerber JS, Newland JG, Coffin SE, et al. Variability in Antibiotic Use at Children’s 
Hospitals. Pediatrics 2010; 126:1067–1073.  
3.  Gerber JS, Kronman MP, Ross RK, et al. Identifying Targets for Antimicrobial 
Stewardship in Children’s Hospitals. Infect Control Hosp Epidemiol 2013; 34:1252–
1258.  
4.  Bronzwaer SLAM, Cars O, Buchholz U, et al. The Relationship between Antimicrobial 
Use and Antimicrobial Resistance in Europe. Emerg Infect Dis 2002; 8:278–282.  
5.  Lipsitch M, Samore MH. Antimicrobial Use and Antimicrobial Resistance: A 
Population Perspective - Volume 8, Number 4—April 2002 - Emerging Infectious 
Diseases journal - CDC. Available at: https://wwwnc.cdc.gov/eid/article/8/4/01-
0312_article. Accessed 12 September 2019. 
6.  Chiotos K, Tamma PD, Flett KB, et al. Increased 30-Day Mortality Associated With 
Carbapenem-Resistant Enterobacteriaceae in Children. Open Forum Infect Dis 2018; 5. 







/cid/advance-article-abstract/doi/10.1093/cid/ciaa036/5707319 by St G
eorge's U
niversity of London user on 07 February 2020
 
 17 
7.  Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United 
States, 2013. Available at: https://www.cdc.gov/drugresistance/threat-report-
2013/pdf/ar-threats-2013-508.pdf. Accessed 12 September 2019. 
8.  O’Neill J. Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a 
Crisis for the Health and Wealth of Nations. 2014. Available at: https://amr-
review.org/sites/default/files/AMR Review Paper - Tackling a crisis for the health and 
wealth of nations_1.pdf. Accessed 27 May 2019. 
9.  Wendt JM, Cohen JA, Mu Y, et al. Clostridium difficile Infection Among Children 
Across Diverse US Geographic Locations. Pediatrics 2014; 133:651–658.  
10.  Shehab N, Lovegrove MC, Geller AI, Rose KO, Weidle NJ, Budnitz DS. US 
Emergency Department Visits for Outpatient Adverse Drug Events, 2013-2014. JAMA 
2016; 316:2115–2125.  
11.  Schmidt ML, Spencer MD, Davidson LE. Patient, Provider, and Practice Characteristics 
Associated with Inappropriate Antimicrobial Prescribing in Ambulatory Practices. 
Infect Control Hosp Epidemiol 2018; 39:307–315.  
12.  Fleming-Dutra KE, Hersh AL, Shapiro DJ, et al. Prevalence of Inappropriate Antibiotic 
Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA 2016; 315:1864.  
13.  Dellit TH, Owens RC, McGowan JE, et al. Infectious Diseases Society of America and 
the Society for Healthcare Epidemiology of America Guidelines for Developing an 







/cid/advance-article-abstract/doi/10.1093/cid/ciaa036/5707319 by St G
eorge's U
niversity of London user on 07 February 2020
 
 18 
14.  Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary Use of 
Antimicrobials in Hospitalized Patients: Current Patterns of Misuse With an Emphasis 
on the Antianaerobic Spectrum of Activity. Arch Intern Med 2003; 163:972.  
15.  Fridkin S, Baggs J, Fagan R, et al. Vital Signs: Improving Antibiotic Use Among 
Hospitalized Patients. MMWR Morb Mortal Wkly Rep 2014; 63:194–200.  
16.  Naqvi SH, Dunkle LM, Timmerman KJ, Reichley RM, Stanley DL, O’Connor D. 
Antibiotic Usage in a Pediatric Medical Center. JAMA 1979; 242:1981–1984.  
17.  Schuler CL, Courter JD, Conneely SE, et al. Decreasing Duration of Antibiotic 
Prescribing for Uncomplicated Skin and Soft Tissue Infections. Pediatrics 2016; 
137:e20151223.  
18.  Ambroggio L, Thomson J, Kurowski EM, et al. Quality Improvement Methods Increase 
Appropriate Antibiotic Prescribing for Childhood Pneumonia. Pediatrics 2013; 
131:e1623–e1631.  
19.  Sviestina I, Mozgis D. Observational Study of Antibiotic Usage at the Children’s 
Clinical University Hospital in Riga, Latvia. Medicina (Mex) 2018; 54:74.  
20.  Gharbi M, Doerholt K, Vergnano S, et al. Using a simple point-prevalence survey to 
define appropriate antibiotic prescribing in hospitalised children across the UK. BMJ 
Open 2016; 6:e012675.  
21.  Mukattash TL, Hayajneh WA, Ibrahim SM, et al. Prevalence and nature of off-label 
antibiotic prescribing for children in a tertiary setting: A descriptive study from Jordan. 






/cid/advance-article-abstract/doi/10.1093/cid/ciaa036/5707319 by St G
eorge's U
niversity of London user on 07 February 2020
 
 19 
22.  EmyInumaru F, Silva AS e, Soares A de S, Schuelter-Trevisol F. Profile and 
Appropriate Use of Antibiotics Among Children in a General Hospital in Southern 
Brazil. Rev Paul Pediatr 2019; 37:27–33.  
23.  Ergül AB, Gökçek İ, Çelik T, Torun YA. Assessment of inappropriate antibiotic use in 
pediatric patients: Point-prevalence study. Turk Arch Pediatr Pediatri Arş 2018; 53:17–
23.  
24.  Gandra S, Singh SK, Jinka DR, et al. Point Prevalence Surveys of Antimicrobial Use 
among Hospitalized Children in Six Hospitals in India in 2016. Antibiotics 2017; 6. 
Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617983/. Accessed 18 
June 2019. 
25.  Hsia Y, Lee BR, Versporten A, et al. Use of the WHO Access, Watch, and Reserve 
classification to define patterns of hospital antibiotic use (AWaRe): an analysis of 
paediatric survey data from 56 countries. Lancet Glob Health 2019; 7:e861–e871.  
26.  Buccellato E, Melis M, Biagi C, Donati M, Motola D, Vaccheri A. Use of Antibiotics in 
Pediatrics: 8-Years Survey in Italian Hospitals. PLOS ONE 2015; 10:e0139097.  
27.  Labi A-K, Obeng-Nkrumah N, Sunkwa-Mills G, et al. Antibiotic prescribing in 
paediatric inpatients in Ghana: a multi-centre point prevalence survey. BMC Pediatr 
2018; 18. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302438/. 
Accessed 3 June 2019. 
28.  Luthander J, Bennet R, Nilsson A, Eriksson M. Antimicrobial Use in a Swedish 
Pediatric Hospital: Results From Eight Point Prevalence Surveys Over a 15-Year Period 






/cid/advance-article-abstract/doi/10.1093/cid/ciaa036/5707319 by St G
eorge's U




iatric_Hospital_.96415.aspx. Accessed 21 June 2019. 
29.  Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H. The Worldwide 
Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence 
survey: developing hospital-quality indicators of antibiotic prescribing for children. J 
Antimicrob Chemother 2016; 71:1106–1117.  
30.  Osowicki J, Gwee A, Noronha J, et al. Australia-wide point prevalence survey of the use 
and appropriateness of antimicrobial prescribing for children in hospital. Med J Aust 
2014; 201:657–662.  
31.  Hulscher ME, Grol RP, van der Meer JW. Antibiotic prescribing in hospitals: a social 
and behavioural scientific approach. Lancet Infect Dis 2010; 10:167–175.  
32.  Newland JG, Gerber JS, Kronman MP, et al. Sharing Antimicrobial Reports for 
Pediatric Stewardship (SHARPS): A Quality Improvement Collaborative. J Pediatr 
Infect Dis Soc 2018; 7:124–128.  
33.  Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic 
Data Capture (REDCap) - A metadata-driven methodology and workflow process for 
providing translational research informatics support. J Biomed Inform 2009; 42:377–
381.  
34.  Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: Building an 







/cid/advance-article-abstract/doi/10.1093/cid/ciaa036/5707319 by St G
eorge's U
niversity of London user on 07 February 2020
 
 21 
35.  Berríos-Torres SI, Umscheid CA, Bratzler DW, et al. Centers for Disease Control and 
Prevention Guideline for the Prevention of Surgical Site Infection, 2017. JAMA Surg 
2017; 152:784–791.  
36.  Hersh AL, De Lurgio SA, Thurm C, et al. Antimicrobial stewardship programs in 
freestanding children’s hospitals. Pediatrics 2015; 135:33–39.  
37.  Smith MJ, Gerber JS, Hersh AL. Inpatient Antimicrobial Stewardship in Pediatrics: A 







/cid/advance-article-abstract/doi/10.1093/cid/ciaa036/5707319 by St G
eorge's U
niversity of London user on 07 February 2020
 
 22 
Table 1. Demographic and Clinical Characteristics of Hospitalized Children Receiving Antibiotics 
 
    Patients (N=11,784) 
Patient Age (years) 3.83 [0.52, 10.96] 
Gender 
  Male 6452 (55.0%) 
 
Female 5273 (45.0%) 
Medical Service Type 
 
 
Medical 5846 (50.6%) 
 
Surgical  1693 (14.6%) 
 
Neonatal Intensive Care  1537 (13.3%) 
 




Invasive Ventilation 2189 (18.7%) 
 
Non-Invasive Ventilation 1408 (12.0%) 
 
No Ventilation 7990 (68.3%) 
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0 2684 (22.8%) 
 
1 5014 (42.6%) 
 
2 2627 (22.3%) 
 
3 or more 1433 (12.2%) 
Documented History of Adverse Antibiotic Reaction 
 
 
No 10034 (85.3%) 
 
Yes 1733 (14.7%) 
Calendar Quarter of Survey 
 
 
2016-Q3 2136 (18.1%) 
 
2016-Q4 2324 (19.7%) 
 
2017-Q1 2205 (18.7%) 
 
2017-Q2 1965 (16.7%) 
 
2017-Q3 1798 (15.3%) 




Includes children (0-17 years of age) with an order for1 antibiotic (prescribed for infectious 
indications, via enteral, parenteral, inhaled, or rectal routes) at 0800 on quarterly survey days. 
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value 95% CI 
Indication for Antibiotic Use     
Prophylaxis for medical problems 
 
-ref- --- --- 
Cardiac infections 
 
0.66 0.171 0.36, 1.20 
Febrile neutropenia/fever 
 
0.79 0.079 0.61, 1.03 
Gastrointestinal tract infections 
 
1.12 0.324 0.89, 1.41 
Joint/bone infections 
 
1.00 0.999 0.70, 1.42 
Miscellaneous 
 
0.77 0.301 0.46, 1.27 
Probable/proven central nervous system infections 
 
0.90 0.490 0.67, 1.21 
Probable/proven catheter-related bloodstream infection 
 
1.36 0.021 1.05, 1.75 
Probable/proven sepsis; rule-out serious bacterial infection in 
infant 
 
1.48 0.001 1.21, 1.81 
Prophylaxis for surgical problems 
 
4.39 <.0001 3.51, 5.49 
Probable/proven bacterial lower respiratory tract infection 
 
1.68 <.0001 1.39, 2.03 





Pyrexia of unknown origin 
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Skin/soft tissue infections 
 
1.43 0.005 1.11, 1.82 
Treatment for surgical disease 
 
0.97 0.806 0.73, 1.27 
Unknown 
 
4.82 <.0001 3.58, 6.49 
Upper respiratory infections 
 
2.97 <.0001 2.34, 3.78 
Urinary tract infections 
 
2.70 <.0001 2.11, 3.46 
    
Antibiotic Class 
    Narrow-spectrum penicillin 
 
-ref- --- --- 
1st generation cephalosporin 
 
1.05 0.644 0.85, 1.31 
2nd generation cephalosporin 
 
1.32 0.166 0.89, 1.96 
Enteral 3rd generation cephalosporin 
 
3.70 <.0001 2.34, 5.85 
Parenteral 3rd generation cephalosporin 
 
1.71 <.0001 1.43, 2.04 
Aminoglycoside 
 
1.15 0.184 0.94, 1.41 
Aminopenicillin and beta-lactamase inhibitor 
 
1.52 0.001 1.20, 1.92 
Antipseudomonal beta-lactam 1.52 <.0001 1.28, 1.80 
Broad-spectrum gram-positive agent  2.49 <.0001 1.64, 3.77 
Carbapenem  2.89 <.0001 2.29, 3.64 
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Fluoroquinolone  2.52 <.0001 1.99, 3.19 
Macrolide  1.30 0.085 0.96, 1.75 
Metronidazole  1.87 <.0001 1.46, 2.39 
Miscellaneous  1.09 0.578 0.80, 1.50 
Sulfamethoxazole and trimethoprim  0.63 <.0001 0.50, 0.79 
Vancomycin  2.07 <.0001 1.73, 2.49 
     
Indication for Antibiotic Use not Documented in Notes  1.49 <.0001 1.30, 1.70 
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Figure 1: Most Commonly Prescribed Antibiotics and Percentage Suboptimal 
Top 10 most frequently ordered antibiotics for children hospitalized on six quarterly survey days (Q3 
2016 – Q4 2017). Antibiotics were classified as suboptimal (inappropriate and/or needing 
modification) by hospital antimicrobial stewardship programs.  
 
 
Figure 2: Most Common Indications for Antibiotic Use and Percentage Suboptimal 
Top 10 most common indications for antibiotics ordered for children hospitalized on six quarterly 
survey days (Q3 2016 – Q4 2017). Antibiotics were classified as suboptimal (inappropriate and/or 
needing modification) by hospital antimicrobial stewardship programs. Abbreviations: LRTI (lower 




Figure 3. Suboptimal Antibiotic Use Across Hospitals 
Percentage of patients receiving antibiotics who were prescribed 1 suboptimal antibiotic. Each bar 
represents one hospital.  
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Antimicrobial stewardship programs classified 2 293 (13.5%) of 16 960 antibiotics ordered for 
children hospitalized on survey days as inappropriate. See Supplemental Material, Appendices A 
(pre-specified reasons on survey) and C (post-hoc reason categories) for further explanation of 
inappropriate reasons. 
 
Figure 5. Recommended Modifications for Suboptimal Antibiotic Orders 
Antibiotics were classified as suboptimal (inappropriate and/or needing modification) by hospital 
antimicrobial stewardship programs. Of 16 891 antibiotics with this composite outcome assessed, 3 
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